Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
Researchers create a new robotic surgery device that aims to give surgeons “superhuman” hands, accounting for patients’ breathing and eye movements, along with their own involuntary hand tremors, while they work on retinal tissues.
New findings from a National Eye Institute-led study add a twist on how a widely used cell death marker, annexin-V, can be interpreted in the lab and the clinic for tracking retinal cell death in eye diseases such as glaucoma.
National Eye Institute-funded scientists using gene editing corrected a mutation in a mouse model of retinitis pigmentosa, an inherited blinding eye disorder. The gene editing strategy restored production of rhodopsin, and retinal function and structure
Research team has identified advanced preclinical candidates targeting the bisretinoid synthesis pathway, which could help treat macular degeneration and Stargardt disease.
New data demonstrate how social determinants of health can fuel disparities in monitoring for diabetic retinopathy for patients of different racial and ethnic groups.
Researchers are searching for a new treatment target for a common complication of diabetes that can cause retinal blood vessels to break down, leak or become blocked.
A new study at the University of Houston College of Optometry will track the health of patients with prediabetes and diabetes to find out who might develop eye problems and be at risk for future vision loss.
Researchers from the National Institutes of Health (NIH) have discovered the source of dysfunction in the process whereby cells in the eye's retina remove waste.